ACADIA Pharmaceuticals Inc. (ACAD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ACADIA Pharmaceuticals In...

    NASDAQ: ACAD · Real-Time Price · USD
    25.26
    -0.24 (-0.94%)
    At close: Sep 05, 2025, 3:59 PM
    25.05
    -0.83%
    After-hours: Sep 05, 2025, 06:48 PM EDT

    ACADIA Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 319.59M 188.66M 114.85M 147.44M
    Short-Term Investments
    		 436.4M 250.21M 301.98M 373.27M
    Long-Term Investments
    		 n/a 5.77M 12.97M 9.37M
    Other Long-Term Assets
    		 78.87M 5.1M 5.31M 6.61M
    Receivables
    		 104.69M 102.35M 63.08M 65.34M
    Inventory
    		 21.95M 35.82M 6.64M 7.88M
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 938.32M 616.13M 507.94M 617.82M
    Property-Plant & Equipment
    		 50.79M 56.47M 61.59M 66.31M
    Goodwill & Intangibles
    		 119.78M 65.49M n/a n/a
    Total Long-Term Assets
    		 249.44M 132.83M 79.88M 82.3M
    Total Assets
    		 1.19B 748.96M 587.81M 700.12M
    Account Payables
    		 16.19M 17.54M 12.75M 6.88M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 114.28M 92.31M 49.51M 39.27M
    Total Current Liabilities
    		 394.87M 254.25M 125.63M 96.07M
    Long-Term Debt
    		 n/a n/a n/a 56.13M
    Other Long-Term Liabilities
    		 18.06M 15.15M 9.07M -49.09M
    Total Long-Term Liabilities
    		 60.09M 62.95M 61.77M 63.16M
    Total Liabilities
    		 454.96M 317.2M 187.4M 159.23M
    Total Debt
    		 51.99M 57.2M 62M 56.13M
    Common Stock
    		 16K 16K 16K 16K
    Retained Earnings
    		 -2.2B -2.43B -2.37B -2.15B
    Comprehensive Income
    		 292K 24K -975K -192K
    Shareholders Equity
    		 732.79M 431.75M 400.41M 540.89M
    Total Investments
    		 436.4M 255.98M 301.98M 373.27M

    Add to Watchlist